PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-04-06

Date Title Company
06-Apr-2023 IQVIA to Announce First-Quarter 2023 Results on April 27, 2023 Businesswire
06-Apr-2023 Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor Businesswire
06-Apr-2023 AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023 Businesswire
06-Apr-2023 Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
06-Apr-2023 USA leads the Americas COVID-19 Testing Market during the forecast period 2023 to 2033 | FMI Analyst MARKITWIRED
06-Apr-2023 Endodontics and Orthodontics Market is expected to expand at a 5.3% CAGR through 2032 | FMI MARKITWIRED
06-Apr-2023 Alpha Cancer Technologies (ACT) Publishes Pre-Clinical Study Results in Cancer Cell International Demonstrating Excellent Safety and Significant Anti-Tumor Activity from the Company’s Next Generation ADC, ACT-903 Businesswire
06-Apr-2023 Mauna Kea Technologies publie ses résultats annuels 2022 Businesswire
06-Apr-2023 TP ICAP Midcap Initiates Coverage of Pherecydes Pharma With a “Buy” Recommendation Businesswire
06-Apr-2023 Mauna Kea Technologies Reports 2022 Annual Results Businesswire
06-Apr-2023 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill Vita 34 AG
06-Apr-2023 RQM+ Appoints Denise Wocko as Head of Global Client Portfolio Management Businesswire
06-Apr-2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy Businesswire
06-Apr-2023 Boston BioProducts Receives ISO 13485:2016 Quality Certification Businesswire
06-Apr-2023 restor3d Receives FDA Clearance of Patient Specific Resection Guides for use with the Kinos Axiom Total Ankle System Businesswire
06-Apr-2023 VanEck Launches Robotics ETF (IBOT) Businesswire
06-Apr-2023 Industry Leader Tim Walbert Joins Mirum Pharmaceuticals’ Board of Directors Businesswire
06-Apr-2023 Ora, Inc. Appoints Paul Colvin as Chief Operating Officer Businesswire
06-Apr-2023 Vistagen Receives New European Patent for AV-101 Businesswire
06-Apr-2023 Affini-T Therapeutics to Present Preclinical Data from its Oncogenic Driver Program Targeting KRAS at the American Association for Cancer Research (AACR) Annual Meeting 2023 Businesswire